Irradiation stent with 125I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial

MLA

Jian Lu, et al. “Irradiation Stent with 125I plus TACE versus Sorafenib plus TACE for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Multicenter Randomized Trial.” International Journal of Surgery, vol. 109, Apr. 2023, pp. 1188–98. EBSCOhost, https://doi.org/10.1097/js9.0000000000000295.

APA

Jian Lu, Jin-He Guo, Jian-Song Ji, Yu-Liang Li, Wei-Fu Lv, Hai-Dong Zhu, Jun-Hui Sun, Wei-Xin Ren, Fu-Jun Zhang, Wei-Dong Wang, Hai-Bo Shao, Guang-Shao Cao, Hai-Liang Li, Kun Gao, Po Yang, Guo-Wen Yin, Guang-Yu Zhu, Fa-Zong Wu, Wu-Jie Wang, … Gao-Jun Teng. (2023). Irradiation stent with 125I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial. International Journal of Surgery, 109, 1188–1198. https://doi.org/10.1097/js9.0000000000000295

Chicago

Jian Lu, Jin-He Guo, Jian-Song Ji, Yu-Liang Li, Wei-Fu Lv, Hai-Dong Zhu, Jun-Hui Sun, et al. 2023. “Irradiation Stent with 125I plus TACE versus Sorafenib plus TACE for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Multicenter Randomized Trial.” International Journal of Surgery 109 (April): 1188–98. doi:10.1097/js9.0000000000000295.